Compare Cytokinetics Inc (CYTK) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Lufax Holding Ltd — how do they compare? Cytokinetics Inc trades at $77 (market cap $10.63B), while Lufax Holding Ltd trades at $1.54 (market cap $2.41B). The key difference: Cytokinetics Inc is far larger — about 4.4× Lufax Holding Ltd's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| CYTK | LU | |
|---|---|---|
Market Cap | $10.63B | $2.41B |
Sector | Technology | Technology |
52-Week High | $87.26 | $4.40 |
52-Week Low | $34.31 | $1.23 |
Enterprise Value | $10.74B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
